CLEVELAND, June 4, 2018 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that James F. Dempsey, PhD, Founder and Chief Scientific Officer, and Ajay Bansal, Chief Financial Officer, are scheduled to present at the Jefferies 2018 Global Healthcare Conference in New York, NY.
Event: Jefferies 2018 Global Healthcare ConferenceDate: Friday, June 8, 2018Time: 10:30am ET
An audio webcast of the Company's presentation will be available on the investor relations section of ViewRay's website at www.viewray.com. A replay of the webcast will be available for 7 days after the date of the presentation.
About ViewRayViewRay®, Inc. (Nasdaq: VRAY), designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purposely built to deliver high-precision radiation without unnecessary beam distortion, and consequently, help to mitigate skin toxicity and other safety concerns that may otherwise arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
View original content:http://www.prnewswire.com/news-releases/viewray-to-present-at-the-jefferies-2018-global-healthcare-conference-300658106.html
SOURCE ViewRay, Inc.
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All